Johnson And Johnson is in the drug manufacturers industry and trades as part of the healthcare sector. The company CEO is Alex Gorsky. Johnson and Johnson is a holding company, which is engaged in the research and development, manufacture and sale of products in the health care field within its Consumer, Pharmaceutical and Medical Devices segments.
Previous Intraday Trading Performance:
The JNJ stock showed a previous change of 0.01% with an open at 139.50 and a close of 138.85. It reached an intraday high of 139.50 and a low of 138.56.
The stock has a market cap of $368.7b with 2.7b shares outstanding, of which the float is 2.7b shares. Trading volume reached 5,472,539 shares compared to its average volume of 6,228,417 shares. Based on the current average volume and close price, the trading liquidity is good.
Historical Trading Performance:
Over the last five trading days, Johnson And Johnson shares returned 1.00% and in the past 30 trading days it returned 2.81%. Over three months, it changed 2.64%. In one year it has changed 17.48% and within that year its 52-week high was 148.99 and its 52-week low was 118.62. JNJ stock is 17.05% above its 52 Week Low.
Our calculations show a 200 day moving average of 135.05 and a 50 day moving average of 137.42. Currently JNJ stock is trading 2.81% above its 200 day moving average and may be a good opportunity to buy.
SeekingAlpha: Oklahoma opioid claims cost Teva $85M
The last annual fiscal EPS for the company was reported at 5.61 that ended on 31st of December 2018, which according to the previous close, that is a PE of 24.75. Based on 8 analyst estimates, the consensus EPS for the next quarter is 2.04. The TTM EPS is 8.18, which comes to a TTM PE of 16.97. Historically, the PE high was 310.40 and the PE low was 14.30. If the stock reached its PE low, that would represent a price of 117.00, which is a decrease of -15.73%.
Below was the last reported quarterly diluted earnings per share:
|1st||Qtr of 2019||1.39|
|4th||Qtr of 2018||1.12|
|3rd||Qtr of 2018||1.44|
|2nd||Qtr of 2018||1.45|
|1st||Qtr of 2018||1.60|
The dividend per share is currently 3.80, which is a dividend yield of 2.74%. Also, the payout ratio is 46.45%, therefore the dividend is safe according to our calculations.
Base on our calculations, the intrinsic value per share is 209.73, which means it is possibly undervalued and has a margin of safety of 33.79%.
Indicators to Watch:
Based on the latest filings, there is 96.10% of institutional ownership. Short-interest was 11,236,255, which was 0.42% of shares outstanding. The short-interest ratio or days-to-cover ratio was 1.93. This stock has some short interest, but it may be normal and no cause for concern if long the position.
The current calculated beta is 0.66.
Based on last reported financials, the company’s return on equity is 24.54%, return on assets is 9.78%, profit margin is 18.02%, price-to-sales is 4.52 and price-to-book is 6.25.
All scores are out of six:
1 :Valuation Score
4 :Past Performance Score
3 :Financial Strength Score
2 :Future Growth Score
5 :Dividend Score
3 :Overall Score